Novopulmon Novolizer (Budesonide)

Budesonide, the active ingredient in Novopulmon Novolizer, is a glucocorticoid presented as a inhalation powder for respiratory use. It treats airway inflammation in asthma and chronic obstructive pulmonary disease (COPD) in adults and children. GNH USA supplies Novopulmon Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novopulmon Novolizer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novopulmon Novolizer contains budesonide, a corticosteroid that acts on the inflammatory pathway of the respiratory tract.

- Asthma: improves control of symptoms and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): decreases airway inflammation and helps maintain lung function. - Allergic rhinitis: alleviates nasal inflammation when used as directed for upper airway symptoms.

Adverse reactions may occur with inhaled budesonide, ranging from mild to serious.

Common Side Effects: - Oral candidiasis: fungal infection of the mouth. - Hoarseness: voice changes after inhalation. - Throat irritation: mild discomfort in the throat. - Cough: transient coughing after use. - Upper respiratory tract infection: mild cold‑like symptoms.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of breathing difficulty. - Adrenal suppression: reduced cortisol production with high‑dose or prolonged use. - Pneumonia: infection of the lung tissue, especially in COPD patients. - Glaucoma or cataract progression: increased intra‑ocular pressure. - Systemic glucocorticoid effects: bruising, skin thinning, or growth retardation in children.

When using Novolizer, follow safety guidelines to minimise risks.

- Monitor lung function: assess response and adjust therapy as needed. - Use a spacer: reduces oropharyngeal deposition and irritation. - Rinse mouth after inhalation: helps prevent oral candidiasis. - Review concomitant medications: avoid unnecessary systemic steroids. - Assess for infections: watch for signs of pneumonia or tuberculosis. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Budesonide may interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): increase systemic exposure. - Systemic glucocorticoids: additive immunosuppressive effects.

Moderate Interactions (Monitor Closely): - Antifungal S   - Antifungal S   - Antifstrong  - Antifungal  -